Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

Erstveröffentlichung
2021Authors
Khunti, Kamlesh
Kosiborod, Mikhail
Kim, Dae Jung
Kohsaka, Shun
Lam, Carolyn S. P.
Wissenschaftlicher Artikel
Published in
Cardiovascular Diabetology ; 20 (2021). - Art.-Nr. 159. - eISSN 1475-2840
Link to publication
https://dx.doi.org/10.1186/s12933-021-01345-zFaculties
Medizinische FakultätInstitutions
Institut für Epidemiologie und Medizinische BiometrieSubject headings
[Free subject headings]: Sodium-glucose cotransporter-2 inhibitors | Cardiovascular outcomes | Heart failure | Type 2 diabetes | RISK | INITIATION | THERAPIES | MORTALITY | TRIALS | DEATH | ASIA[DDC subject group]: DDC 610 / Medicine & health